Literature DB >> 32018

The role of the septo-hippocampal system and its noradrenergic afferents in behavioural responses to none-reward.

J A Gray, J Feldon, J N Rawlins, S Owen, N McNaughton.   

Abstract

Our experiments were designed with two purposes: (i) to examine the effects on one behaviour of differing interventions in the septo-hippocampal system; (ii) to compare these effects with those of minor tranquillizers. The behaviour studied (in rats) is extinction in the alley after continuous (CRF) or partial (PRF) reinforcement. Minor tranquillizers and large septal lesions produce three effects: (1) resistance to extinction is increased after CRF; (2) resistance to extinction is decreased after PRF; (3) the partial reinforcement extinction effect (PREE) is abolished. Small septal lesions fractionate this syndrome: either effect (1) or an actual increase in the size of the PREE is produced by medial septal lesions abolishing hippocampal theta; effects (2) and (3), but not (1), are produced by lateral septal lesions sparing theta. Dorso-medial fornix section, abolishing theta, reproduces the effects of medial septal lesions. Fimbrial section, sparing theta, reproduces some of the effects of lateral septal lesions. Minor tranquillizers produce a rise in the threshold for septal driving of hippocampal theta specifically at 7.7 Hz. This effect is reproduced by blockade of noradrenergic transmission or destruction of the dorsal noradrenergic bundle with 6-hydroxydopamine. This lesion reproduces all three behavioural changes listed above. These results suggest a model for the role of the septo-hippocampal system and its noradrenergic inputs in the PREE. This model is compared with other approaches to the septo-hippocampal system.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 32018     DOI: 10.1002/9780470720394.ch12

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  11 in total

1.  Electrolytic lesions of the nucleus accumbens in rats which abolish the PREE enhance the locomotor response to amphetamine.

Authors:  C T Tai; A J Clark; J Feldon; J N Rawlins
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  The role of subicular outputs in the development of the partial reinforcement extinction effect.

Authors:  J N Rawlins; J Feldon; J Tonkiss; P J Coffey
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

3.  Septo-hippocampal connections and the hippocampal theta rhythm.

Authors:  J N Rawlins; J Feldon; J A Gray
Journal:  Exp Brain Res       Date:  1979-09       Impact factor: 1.972

4.  The effects of intra-subicular ibotenate on resistance to extinction after continuous or partial reinforcement.

Authors:  J D Sinden; L E Jarrard; J A Gray
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

5.  The effects of intrahippocampal ibotenate on resistance to extinction after continuous or partial reinforcement.

Authors:  L E Jarrard; J Feldon; J N Rawlins; J D Sinden; J A Gray
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  The effects of hippocampectomy and of fimbria section upon the partial reinforcement extinction effect in rats.

Authors:  J N Rawlins; J Feldon; J A Gray
Journal:  Exp Brain Res       Date:  1980-02       Impact factor: 1.972

7.  Fornix-fimbria section and the partial reinforcement extinction effect.

Authors:  J Feldon; J N Rawlins; J A Gray
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

8.  Hippocampal lesions do not alter the partial punishment effect.

Authors:  S Brookes; J N Rawlins; J A Gray
Journal:  Exp Brain Res       Date:  1983       Impact factor: 1.972

9.  The partial reinforcement extinction effect: influence of chlordiazepoxide in septal lesioned rats.

Authors:  J Feldon; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Effects of RO 15-1788 on a running response rewarded on continuous or partial reinforcement schedules.

Authors:  M Hawkins; J Sinden; I Martin; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.